Could your own cells heal kidneys after heart surgery?

NCT ID NCT07052513

Recruiting now Disease control Sponsor: M2RLAB SL Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a patient's own modified white blood cells can help kidneys recover faster after acute injury from heart surgery. About 98 adults will receive either the cell therapy or a placebo. The goal is to see if the treatment shortens recovery time and is safe.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: modified white blood cells (autologous leukocyte cells)
What this could lead to: If it works, this could offer a new treatment to help kidneys recover faster after heart surgery, reducing the need for dialysis.
What could go wrong: This is an early Phase 2 trial with only 98 participants, so results may not apply to everyone. The treatment involves infusing modified cells, which carries risks like infection or immune reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute kidney injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE KIDNEY INJURY

Contacts and locations

Locations

Hospital Clinic of Barcelona
RECRUITING

Barcelona, Catalonia, 08036, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.